Related Experiment Video
Updated: Oct 1, 2025
03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
958
Eosinophilic airway diseases: basic science, clinical manifestations and future challenges
Christer Janson1, Leif Bjermer2, Lauri Lehtimäki3,4
1Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
European Clinical Respiratory Journal
|March 7, 2022
Summary
Eosinophilic airway diseases are driven by type 2 inflammation. Biologic therapies show promise, but further research is needed to predict treatment response using real-world data from Nordic patient registries.
Area of Science:
- Immunology and Respiratory Medicine
- Focuses on eosinophil function and type 2 inflammation in airway diseases.
Background:
- Eosinophils play crucial roles in both health and disease, regulated by cytokines like interleukin-5.
- Type 2 inflammation (IL-4, IL-5, IL-13) is central to eosinophilic airway diseases such as asthma and EGPA.
Purpose of the Study:
- To review the role of type 2 inflammation in eosinophilic airway diseases.
- To discuss current biologic therapies and identify research challenges.
- To highlight the potential of Nordic patient registries for future research.
Main Methods:
- Literature review of eosinophil function, type 2 inflammation, and biologic therapies.
- Analysis of challenges in predicting treatment response.
- Introduction of the NORdic Dataset for aSThmA Research (NORDSTAR) as a valuable resource.
Main Results:
- Biologic therapies targeting type 2 inflammation offer clinical benefits for eosinophilic diseases.
- Challenges remain in understanding disease progression and identifying predictive biomarkers.
- Nordic asthma registries, like NORDSTAR, offer large-scale, real-world data for research.
Conclusions:
- Further research is essential to optimize targeted treatments for eosinophilic airway diseases.
- Real-world data from large patient registries can identify treatable traits and improve treatment prediction.
- Collaboration using Nordic registries holds significant potential for advancing eosinophilic disease research.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
3.2K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.2K
01:20Asthma: Pathogenesis and Management
793
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
793
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.2K
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:20COPD: Pathogenesis and Clinical Features
659
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
659
01:30Asthma-IV: Diagnostic and Management
2.7K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K